Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
19.93
+0.57 (2.94%)
At close: May 12, 2025, 4:00 PM
19.78
-0.15 (-0.75%)
After-hours: May 12, 2025, 4:05 PM EDT
Genmab Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Genmab stock have an average target of 39.17, with a low estimate of 27 and a high estimate of 48. The average target predicts an increase of 96.54% from the current stock price of 19.93.
Analyst Consensus: Buy
* Price targets were last updated on Apr 9, 2025.
Analyst Ratings
The average analyst rating for Genmab stock from 9 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 2 | 2 | 3 | 4 | 4 | 4 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 1 | 1 | 1 | 1 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 9 | 10 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $50 → $37 | Strong Buy | Reiterates | $50 → $37 | +85.65% | Apr 9, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $50 → $45 | Strong Buy | Maintains | $50 → $45 | +125.79% | Mar 11, 2025 |
| William Blair | William Blair | Hold → Buy Upgrades n/a | Hold → Buy | Upgrades | n/a | n/a | Mar 11, 2025 |
| Leerink Partners | Leerink Partners | Hold → Buy Upgrades $27 | Hold → Buy | Upgrades | $27 | +35.47% | Feb 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +150.88% | Jan 23, 2025 |
Financial Forecast
Revenue This Year
24.41B
from 21.53B
Increased by 13.38%
Revenue Next Year
28.16B
from 24.41B
Increased by 15.36%
EPS This Year
106.15
from 121.36
Decreased by -12.53%
EPS Next Year
127.16
from 106.15
Increased by 19.79%
Financial currency is DKK. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 27.2B | 33.2B | 39.8B | ||
| Avg | 24.4B | 28.2B | 33.5B | ||
| Low | 3.5B | 4.0B | 28.2B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 26.1% | 36.1% | 41.4% | ||
| Avg | 13.4% | 15.4% | 19.0% | ||
| Low | -83.8% | -83.4% | -0.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 139.40 | 154.12 | 194.49 | ||
| Avg | 106.15 | 127.16 | 156.10 | ||
| Low | 81.78 | 94.71 | 114.90 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 14.9% | 45.2% | 52.9% | ||
| Avg | -12.5% | 19.8% | 22.8% | ||
| Low | -32.6% | -10.8% | -9.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.